News & Updates

Show Multimedia Only
Glucose-lowering medications protect against glaucoma, AMD

Glucose-lowering medications protect against glaucoma, AMD

29 Jul 2022

While diabetes is a risk factor for cataract, glucose-lowering medications appear to have a protective effect on the risks of open-angle glaucoma (OAG) and age-related macular degeneration (AMD), as shown in a study.

29 Jul 2022
Paternal IBD medication use before conception carries no excess risk of childhood infections

Paternal IBD medication use before conception carries no excess risk of childhood infections

28 Jul 2022

Fathers’ exposure to anti-inflammatory or immunosuppressive medications for inflammatory bowel disease (IBD) prior to conception does not appear to contribute to a significantly increased risk of childhood infections, a study has found.

28 Jul 2022
Short-course quinolones, pivmecillinam on par with standard regimens in uncomplicated cystitis

Short-course quinolones, pivmecillinam on par with standard regimens in uncomplicated cystitis

27 Jul 2022 byJairia Dela Cruz

For women with acute uncomplicated cystitis, treatment regimens that include third- and fourth-generation quinolones and pivmecillinam can be administered in shorter courses, which perform similarly to the currently recommended regimens in terms of achieving symptomatic cure, according to the results of a meta-analysis presented at the 37th Annual European Association of Urology (EAU) Congress.

27 Jul 2022
Maternal vaccination reduces COVID-19 hospitalization risk in offspring

Maternal vaccination reduces COVID-19 hospitalization risk in offspring

27 Jul 2022 byElaine Soliven

Full vaccination (two doses) with an mRNA COVID-19 vaccine during pregnancy was associated with a reduced risk of COVID-19-related hospitalization among infants younger than 6 months of age, according to a recent study.

27 Jul 2022
Myopericarditis risk after COVID-19 vaccine not greater than after other vaccines

Myopericarditis risk after COVID-19 vaccine not greater than after other vaccines

26 Jul 2022 byRoshini Claire Anthony

The risk of myopericarditis after COVID-19 vaccination is not greater than that following other non–COVID-19 vaccinations, according to a systematic review and meta-analysis conducted by researchers in Singapore.

26 Jul 2022
UltraVIOLET: Oteseconazole turns in satisfactory results for recurrent yeast infection

UltraVIOLET: Oteseconazole turns in satisfactory results for recurrent yeast infection

26 Jul 2022 byJairia Dela Cruz

In the treatment and prevention of recurrent yeast infection or vulvovaginal candidiasis, oteseconazole performs similarly to standard-of-care fluconazole but better as compared with placebo, as shown in the results of the phase III ultraviolet study.

26 Jul 2022